Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MEDI-528 in Adults With Atopic Asthma
NCT00483041Phase 2Terminated
- Sponsor
- MedImmune
- Start
- Jul 2007
- Primary completion
- Oct 2008
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of enokizumab, sponsored by MedImmune. Started Jul 2007; status: terminated.
02
Drugs
enokizumab
Beyond the preview
Go deeper on NCT00483041.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00483041.